JF
CRBU icon

Jump Financial’s Caribou Biosciences CRBU Stock Holding History

Jump Financial’s Portfolio CRBU Stock Details CRBU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-12,460
Closed -$23.7K – 2098
2026
Q1 		$23.7K Buy
+12,460
New +$21.4K ﹤0.01% 1806
2025
Q3 		– Sell
-14,207
Closed -$17.9K – 1855
2025
Q2 		$17.9K Buy
+14,207
New +$14K ﹤0.01% 1734
2024
Q2 		– Sell
-11,954
Closed -$61.4K – 1872
2024
Q1 		$61.4K Buy
+11,954
New +$73.7K ﹤0.01% 1823
2023
Q4 		– Sell
-92,204
Closed -$441K – 1859
2023
Q3 		$441K Buy
+92,204
New +$572K 0.02% 1088
2023
Q2 		– Sell
-27,200
Closed -$144K – 1856
2023
Q1 		$144K Sell
27,200
-15,464
-36% -$96.3K 0.01% 1379
2022
Q4 		$268K Buy
+42,664
New +$380K 0.01% 1109
2022
Q2 		– Sell
-16,400
Closed -$151K – 1677
2022
Q1 		$151K Buy
+16,400
New +$173K 0.01% 1358

Other funds holding CRBU

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
P
Pfizer New York $170M AUM 191.09% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $100B AUM 36.93% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Jump Financial's CRBU Position: Q2 2026 in Review

Jump Financial sold out of Caribou Biosciences (CRBU) in Q2 2026, closing a stake of 12,460 shares — an estimated $23.7K sold.

Jump Financial first reported a position in CRBU in Q1 2022 and held it in 7 quarters. The position peaked at $441K in Q3 2023. 137 funds tracked by Wall St. Rank hold CRBU as of Q2 2026.

  • Jump Financial reported no remaining Caribou Biosciences position as of Q2 2026 after selling out during the quarter.
  • Jump Financial sold 12,460 Caribou Biosciences shares in Q2 2026, an estimated $23.7K.
  • Jump Financial first reported a position in Caribou Biosciences in Q1 2022 and held it in 7 quarters.
  • Jump Financial's Caribou Biosciences position peaked at $441K in Q3 2023.
  • 137 funds tracked by Wall St. Rank held Caribou Biosciences as of Q2 2026.

Based on Jump Financial's 13F filing for Q2 2026, filed 13 Aug 2026.